Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 193-204 of 424
Drug study icon
RecruitingNCT07226895

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Irvine
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 17 Years to 30 Years
Countries
United States
Sponsor
Monument Therapeutics Limited
Condition
Schizophrenia
Drug study icon
RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

Multiple locations, including Gilbert
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Australia, Canada, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT06159673

ACP-204 in Adults With Alzheimer's Disease Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Chandler
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 95 Years
Countries
United States, France, Brazil, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT07001878

Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including St. John's
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 25 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Schizophrenia
Device study icon
RecruitingNCT07196423

Early Psychosis: Investigating Cognition

This summary needs review. Please check the official study record and contact the research team for details.

In Nottingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
United Kingdom
Sponsor
University of Nottingham
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.